Welcome to the working week, although for some, the routine got under way last night, when an embargo was broken on the release of the Arbiter study (our post is just above this one). In any event, a new day of deadlines and meetings beckons, so on with the show. Grab a cup of something stimulating and dig in. Have a nice one...
UK Tries To Improve Manufacturing Efficiency (PharmaTimes)
Glaxo And Nabi Ink Deal For Anti-Smoking Vaccine (Associated Press)
Bristol-Myers To Split Off Mead Johnson (Associated Press)
Boehringer's Sex Pill Boosted Female Libidos (Bloomberg News)
Glenmark And Medicis Strike Licensing Pact (The Wall Street Journal)